AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Clinicaltrialvanguard

Published November 10, 2026

Faeth's PIKTOR shows 33% response rate in pretreated endometrial cancer

Read the full story at Clinicaltrialvanguard

Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site ... The filing attaches the full press release as Exhibit 99.1 but The 8-K.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelic press release